MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT

A subset of AML patients are unfit for 7+3 induction at the time of diagnosis. Present case highlights the use of azacitidine and venetoclax in a patient with intermediate risk AML with WT-1 mutation,deemed unfit for intensive induction in view of poor general condition and comorbid illness. After v...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Deepak Kumar, Katewa, Satyendra, Porwal, Ravikant, Dara, Ravi, Sharma, Lalit, Sharma, Rahul, Arora, Aadesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436161/
https://www.ncbi.nlm.nih.gov/pubmed/34540583
http://dx.doi.org/10.1016/j.lrr.2021.100267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436161/
https://www.ncbi.nlm.nih.gov/pubmed/34540583
http://dx.doi.org/10.1016/j.lrr.2021.100267

Ejemplares similares